ZA942911B - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
ZA942911B
ZA942911B ZA942911A ZA942911A ZA942911B ZA 942911 B ZA942911 B ZA 942911B ZA 942911 A ZA942911 A ZA 942911A ZA 942911 A ZA942911 A ZA 942911A ZA 942911 B ZA942911 B ZA 942911B
Authority
ZA
South Africa
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Application number
ZA942911A
Inventor
Simon Teanby Hodgson
Peter John Wates
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA942911B publication Critical patent/ZA942911B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
ZA942911A 1993-04-27 1994-04-26 Therapeutic compounds ZA942911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308652A GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds

Publications (1)

Publication Number Publication Date
ZA942911B true ZA942911B (en) 1995-10-26

Family

ID=10734525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942911A ZA942911B (en) 1993-04-27 1994-04-26 Therapeutic compounds

Country Status (6)

Country Link
EP (1) EP0696271A1 (en)
JP (1) JPH08509487A (en)
AU (1) AU6574994A (en)
GB (1) GB9308652D0 (en)
WO (1) WO1994025430A1 (en)
ZA (1) ZA942911B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3322885B2 (en) * 1995-02-02 2002-09-09 日研化学株式会社 N-hydroxyurea derivative
ATE301457T1 (en) * 1995-06-12 2005-08-15 Searle & Co AGENT CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR
WO2005061448A1 (en) * 2003-12-24 2005-07-07 Monash University Compositions and methods for treating vascular conditions
ES2569660T3 (en) 2007-06-08 2016-05-12 Mannkind Corporation IRE-1alpha inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI89709C (en) * 1985-03-16 1993-11-10 Wellcome Found ADJUSTMENT OF THERAPEUTIC MEASURES
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid
JPH02270855A (en) * 1989-02-03 1990-11-05 Wellcome Found Ltd:The Anti-inflammatory aryl compound
JPH06256285A (en) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd Hydroxamic acid derivative and its use
US5169854A (en) * 1992-02-26 1992-12-08 Abbott Laboratories N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity

Also Published As

Publication number Publication date
AU6574994A (en) 1994-11-21
GB9308652D0 (en) 1993-06-09
EP0696271A1 (en) 1996-02-14
JPH08509487A (en) 1996-10-08
WO1994025430A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
EP0714302A4 (en) Therapeutic compounds
GB9421709D0 (en) Therapeutic compounds
GB9300051D0 (en) Therapeutic agents
ZA955644B (en) Therapeutic compounds
GB9310199D0 (en) Therapeutic compounds
GB9307013D0 (en) Therapeutic combinations
AP9400637A0 (en) Therapeutic c compounds
GB9305644D0 (en) Therapeutic agents
ZA946217B (en) Therapeutic combination
ZA942911B (en) Therapeutic compounds
GB9316931D0 (en) Therapeutic compounds
GB9316943D0 (en) Therapeutic compounds
GB9306646D0 (en) Therapeutic agetns
GB9308962D0 (en) Therapeutic agetns
GB9222934D0 (en) Therapeutic compounds
GB9226526D0 (en) Therapeutic compounds
GB9323437D0 (en) Therapy
GB9416629D0 (en) Therapeutic compounds
GB9416632D0 (en) Therapeutic compounds
SI0769017T1 (en) Therapeutic compounds
GB9303243D0 (en) Therapeutic agents
GB9304525D0 (en) Therapeutic agents
GB9307278D0 (en) Therapeutic agents
GB9306031D0 (en) Therapeutic agents
GB9300062D0 (en) Therapeutic agents